EpiPen Outrage Boils To The Surface In California
Parents are deciding whether the prices are worth the peace of mind, or if boycotting the drug will make the company change its tune.
The Orange County Register:
How Much Is Too Much To Spend For Life-Saving Medicines?
The furor over EpiPens, which deliver an injection of epinephrine to open constrained airways, is the latest example of backlash over expensive drugs sold by companies with a monopoly on their product. Rising drug prices, particularly those of specialty drugs to treat cancer or hepatitis C, have been blamed for everything from a double-digit premium hike for California’s 2017 Obamacare policies to straining the state’s Medi-Cal budget for low-income residents. (Perkes, 9/5)
Meanwhile, supporters of the ballot measure to curb high drug prices are seizing the opportunity to push their cause —
Bay Area News Group:
California's Prop. 61 Seeks To Lower Drug Prices, Increase Transparency
Counting on the growing public outrage over the soaring costs of prescription drugs -- and bolstered by the recent fury generated by huge price hikes for lifesaving EpiPens -- Proposition 61 proponents are gearing up for one of the most highly anticipated ballot measure showdowns this election season. (Seipel, 9/5)